Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05544929
Title A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN

Facility Status City State Zip Country Details
Massachusetts General Hospital . RECRUITING Boston Massachusetts 02114 United States Details
NYU School of Medicine RECRUITING New York New York 10015 United States Details
University of Pittsburgh Medical Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Novartis Investigative Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site RECRUITING Dresden 01307 Germany Details
Novartis Investigative Site RECRUITING Essen 45147 Germany Details
Novartis Investigative Site RECRUITING Shatin HONGKONG Hong Kong Details
Novartis Investigative Site RECRUITING Milano MI 20133 Italy Details
Novartis Investigative Site RECRUITING Chuo ku Tokyo 104 0045 Japan Details
Novartis Investigative Site RECRUITING Singapore 119074 Singapore Details
Novartis Investigative Site RECRUITING Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site RECRUITING Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field